Devices/Safety Alert·FDA MedWatch Safety Alerts

Early Alert: Catheter Introducer Kit Issue from Abiomed

HighPublished Jun 2, 2026· AI-analyzed Jun 2, 2026View original FDA source

AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.

What happened

The FDA issued an early alert regarding the Abiomed 14Fr Low Profile Introducer, noting that prolonged use of the device may lead to thrombus formation.

Who it affects

This alert affects Abiomed, clinical staff utilizing the 14Fr Low Profile Introducer kit, and hospital departments involved in interventional cardiology and device reprocessing/management.

Why it matters

The risk of thrombus formation during prolonged use suggests potential limitations in the device's validated performance window or material compatibility over time. This may necessitate a review of instructions for use (IFU), risk management files, and clinical trial protocols to mitigate thromboembolic risks for patients.

Practical takeaway

Clinical teams should assess current protocols regarding the duration of use for the 14Fr Low Profile Introducer. Regulatory and QA departments should prepare for potential labeling updates or field safety notices and ensure post-market surveillance systems are capturing related adverse events.

FDA source material

Prolonged use of the Abiomed 14Fr Low Profile Introducer may lead to thrombus formation

Open in openFDA / FDA.gov

AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.

Early Alert: Catheter Introducer Kit Issue from Abiomed

More from Devices